SMH
VRTX icon

Sanders Morris Harris’s Vertex Pharmaceuticals VRTX Stock Holding History

Sanders Morris Harris’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,350
Closed -$1.12M – 142
2017
Q3 		$1.12M Buy
+7,350
New +$1.11M 0.48% 45

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Morris Harris's VRTX Position: Q4 2017 in Review

Sanders Morris Harris sold out of Vertex Pharmaceuticals (VRTX) in Q4 2017, closing a stake of 7,350 shares — an estimated $1.12M sold.

Sanders Morris Harris first reported a position in VRTX in Q3 2017 and held it in 1 quarter. The position peaked at $1.12M in Q3 2017. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

  • Sanders Morris Harris reported no remaining Vertex Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Sanders Morris Harris sold 7,350 Vertex Pharmaceuticals shares in Q4 2017, an estimated $1.12M.
  • Sanders Morris Harris first reported a position in Vertex Pharmaceuticals in Q3 2017 and held it in 1 quarter.
  • Sanders Morris Harris's Vertex Pharmaceuticals position peaked at $1.12M in Q3 2017.
  • 644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on Sanders Morris Harris's 13F filing for Q4 2017, filed 15 Feb 2018.